
Jean M Dostou MD
Diabetes, Lipid Metabolism
Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Join to view full profile
300 Meadowmont Village CirChapel Hill, NC 27517
Phone+1 984-974-2950
Fax+1 984-974-2924
Dr. Dostou is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1998
University of Rochester Medical CenterResidency, Internal Medicine, 1992 - 1995
The Warren Alpert Medical School of Brown UniversityClass of 1992
Certifications & Licensure
NC State Medical License 1998 - 2027
NY State Medical License 1994 - 2000
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification WebCIS, UNC Health Care, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 116 citationsMulticenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes., Steven J Russell, Roy W Beck, Edward R Damiano, Firas H El-Khatib
The New England Journal of Medicine. 2022-09-29 - 130 citationsAnti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-c...Matthias von Herrath, Stephen C. Bain, Bruce W. Bode, Jesper Ole Clausen, Ken Coppieters
The Lancet. Diabetes & Endocrinology. 2021-04-01 - 235 citationsAlefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patientsMark R. Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc Rendell
The Journal of Clinical Investigation. 2015-08-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: